CLINICAL_TRIALS trial_result · 2011-08-11

Clinical Trial Update: Efficacy and Safety Study of MCI-196 in Patients With Type 2 Diabetes [Phase 2]

A Phase 2 study evaluating the efficacy and safety of MCI-196 in patients with Type 2 diabetes has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Tanabe Pharma Corporation | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2011-08-11